ConductScience.org, home

Gene · 100302178

MIR1295A: microRNA 1295a

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR1295A: microRNA 1295a. Genes, record 100302178. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100302178

On this page

Gene

Symbol
MIR1295A
HGNC
Name
microRNA 1295a
HGNC
NCBI Gene ID
100302178
NCBI Gene
HGNC ID
HGNC:35288
HGNC
Ensembl
ENSG00000221390
NCBI Gene
Aliases
MIR1295, MIRN1295, hsa-mir-1295, hsa-mir-1295a, mir-1295a
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants217

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR1295A papersNewest fiscal year
P30AG072975Rush Alzheimer's Disease Research Center22025
P30CA093373Cancer Center Support Grant P3022025
P30DK056350Nutrition Obesity Research Center (NORC)22025
R35GM119787Neutrophil migration and inflammation22025
U01AG072177KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology22025
U19AG074879Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations22025
IK4BX005219BLR&D Research Career Development Transition Award Application12025
IK6BX004477BLR&D Research Career Scientist Award Application12025
P01HL116263HDL Function in Human Disease12025
P20GM103408Idaho INBRE Program12025

1 to 10 of 217Source NIH's project files

See all 217 nih grants

Papers1,306

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Statement of Retraction: Long non-coding RNA ZFY-AS1 represses periodontitis tissue inflammation and oxidative damage via modulating microRNA-129-5p/DEAD-Box helicase 3 X-linked axis.Bioengineered202642821372PubTator, text miningPubMed
Computational screening of oncogenic genetic variations in tumor suppressor proteins driving gastric cancer pathogenesis.PLoS One202642752674PubTator, text miningPubMed
LncRNASNHG12 regulates the development of diabetic nephropathy through miR-129-5p/IL6ST axis.Mol Biol Rep202642579189PubTator, text miningPubMed
Coordinated gene-catalytic therapy to attenuate intervertebral disc degeneration: A beehive-like nucleic acid nanozyme for microenvironment modulation.J Control Release202642575212PubTator, text miningPubMed
miR-129-5p Modulates the ZEB1/2 Signaling Axis to Suppress Palmitic Acid-Induced Epithelial-Mesenchymal Transition and Barrier Dysfunction in ARPE-19 Cells.J Ocul Pharmacol Ther202642494341PubTator, text miningPubMed
MiR-129-5p is associated with chronic obstructive pulmonary disease status and alleviates cigarette smoke extract-induced human bronchial epithelial cell injury.Tob Induc Dis202642388843PubTator, text miningPubMed
Sonobiopsy for enrichment of circulating microRNAs in glioma patients.Neurooncol Adv202642311796PubTator, text miningPubMed
RETRACTION: Depletion of lncRNA MEG3 Ameliorates Imatinib-Induced Injury of Cardiomyocytes via Regulating miR-129-5p/HMGB1 Axis.Anal Cell Pathol (Amst)202642286935PubTator, text miningPubMed
The Effect of miR-129-5p on the Proliferation and Osteogenic Differentiation of Human Dental Pulp Stem Cells.Int Dent J202642242011PubTator, text miningPubMed
Peripheral miRNA profiling identifies therapy-specific biological trajectories in the treatment of cognitive dysfunction in depression: an exploratory mechanistic study.Sci Rep202642215657PubTator, text miningPubMed

1 to 10 of 1,306

See all 1,306 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/100302178

GET https://conductscience.org/api/genes/v1/100302178/grants?page=2